|
Match
|
Document |
Document Title |
|
|
7417031 |
Use of algae-derived physiologically active substances for treating a carcinomatous disease
Medicinal compositions for treating, ameliorating or preventing diseases with sensitivity to 3,6-anhydrogalactopyranose represented by formula (1):
foods, drinks, cosmetics, etc. containing as...
|
|
|
7417022 |
Compounds and compositions for delivering active agents
Modified amino acid compounds useful in the delivery of active agents are provided. Methods of administration and preparation are provided as well.
|
|
|
7414038 |
Embolic materials
The object of the present invention is to provide an embolizing material which is easily handleable and stable in quality and is solved by providing an embolizing material comprising an ester...
|
|
|
7414021 |
Method and composition for restoration of age related tissue loss in the face or selected areas of the body
A treatment method for restoring of age related tissue loss in the face or selected areas of the body is disclosed which includes injecting an injectable composition containing a growth factor and...
|
|
|
7407945 |
Use of sulfated glycosaminoglycans for establishing effective labor in women
The invention refers to the use of sulfated glycosaminoglycans having an anticoagulant activity of 100 BP units/mg or less for the manufacture of a pharmaceutical preparation for prophylactic...
|
|
|
7407779 |
Modification of solid 3-sn-phosphoglycerides
Methods for hydrolyzing solid ungranulated lysophosphatidylcholine with phospholipase A 2 are provided. Also disclosed are methods for making a lipid matrix of lysophosphatidylcholine,...
|
|
|
7393841 |
Hyperbranched amylopectin for use in methods for surgical or therapeutic treatment of mammals or in diagnostic methods, especially for use as a plasma volume expander
The invention relates to the use of hyperbranched amylopectin which has an average branch degree of between >10 and 25 mol % and a molecular weight (Mw) ranging from 40.000-800.000 Dalton and...
|
|
|
7375095 |
Sugar derivative
For extending the uses of a compound represented by Chemical formula 1, the object of the present invention is to provide a derivative of cyclic tetrasaccharide whose physicochemical properties are...
|
|
|
7375089 |
Rehydration composition
The invention relates to a fluid that can be used for preventing or treating hypohydration and the secondary consequences thereof. The fluid comprises one or more carbohydrates and minerals and is...
|
|
|
7371738 |
Method of transdermal drug delivery using hyaluronic acid nanoparticles
The present invention relates to the development of a hyaluronic acid and hyaluronic acid hybrid nanoparticle systems for the administration of active molecules, peptides, DNA and/or other...
|
|
|
7365192 |
Preparation method of valienamine from acarbose and/or acarbose derivatives using trifluoroacetic acid
The present invention provides a preparation method of valienamine from acarbose or acarbose derivatives using organic acid TFA (trifluoroacetic acid). By using the method of the present invention,...
|
|
|
7365191 |
Type of oligosaccharides and their sulfate derivatives
This invention involves a type of oligosacoharides and its their sulfate derivatives. The backbone of the oligosaccharides consists of 4 to 14 glucose residues, while the side chains contain 0 to 4...
|
|
|
7365059 |
Photocrosslinked-polysaccharide composition and production process of the same
A process for producing a photocrosslinked-polysaccharide composition, which comprises: freezing a photoreactive polysaccharide-containing solution comprising a photoreactive polysaccharide in...
|
|
|
7361644 |
Specific antagonist for both E- and P-selectins
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the...
|
|
|
7354910 |
Agent for treating inflammatory bowel diseases
An agent for treating inflammatory bowel diseases and an agent for preventing or improving symptoms accompanied by inflammatory bowel diseases, which each comprises hyaluronic acid or a...
|
|
|
7354600 |
Muco-adhesive polymers, use thereof and method for producing the same
Mucoadhesive polymers, the use thereof and a production method therefor. Mucoadhesive polymers assembled of not more than 10 different monomers and comprising at least one non-terminal thiol group,...
|
|
|
7351741 |
Compounds and compositions for delivering active agents
Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provide as well.
|
|
|
7348021 |
Immunostimulating coating for surgical devices
The present invention discloses an immunostimulating agent that may be applied to various surgical devices to promote rapid healing and the ready acceptance and integration of the surgical devices...
|
|
|
7345117 |
Sulphated hyaluronic acid and sulphated derivatives thereof covalently bound to polyurethanes, and the process for their preparation
The present invention relates to the synthesis of a haemocompatible polymer, consisting of a polyurethane bound covalently to sulphated hyaluronic acid. These sulfated derivatives have...
|
|
|
7341981 |
Spray composition having a deposition control agent
A spray composition includes an aqueous spray medium, an active ingredient, and a deposition control agent, wherein:
the composition comprises at least one surfactant, and the deposition...
|
|
|
7338943 |
Hyaluronic acid in soft gel form
An orally administered soft gelatin formulation preparation of low molecular weight Hyaluronic Acid (HA) for use as a nutritional supplement to provide the primary benefit of internally causing the...
|
|
|
7338942 |
Composition and method for maintaining healthy mobile joints and cartilage
Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a...
|
|
|
7335384 |
Nutrient compositions for the treatment and prevention of inflammation and disorders associated therewith
The present disclosure describes a novel composition for the treatment and/or prevention of neurogenic inflammation. Such composition is also useful in the treatment and/or prevention of disease...
|
|
|
7332323 |
Strain of Sphingomonas pituitosa and method of exopolysaccharide production therefrom
The present invention concerns a new epoxypolysaccharide-producing bacterium, the exopolysaccharide isolated from this bacterium and the use of the exopolysaccharide.
|
|
|
7323540 |
Process for preparing microrods using liquid-liquid dispersion
The invention provides a method for forming polymer microrods, the method including the steps of providing a polymer solution comprising a polymer dissolved in a first solvent; providing a...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7323329 |
Methods for production of hyaluronic acid, and isolated strains of supercapsulated streptococci
Isolated strains of supercapsulated streptococci band at a density of no greater than 1.03 g/cm 3 in a Percoll gradient and are capable of producing hyaluronic acid with molecular weight...
|
|
|
7322369 |
Methods of detaching microorganisms from, or of inhibiting microbial attachment to, animal or poultry carcasses or seafood or parts thereof
Methods of detaching microorganisms (e.g., bacteria) from, or of inhibiting microbial (e.g., bacterial) attachment to, animal or poultry carcasses or seafood or parts thereof, wherein the method...
|
|
|
7320962 |
Hemoactive compositions and methods for their manufacture and use
Dried hemoactive materials comprise both a cross-linked biologically compatible polymer and a non-cross-linked biologically compatible polymer. The cross-linked polymer is selected to form a...
|
|
|
7314860 |
Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
The present invention is related to heparin-like compounds characterized by their capacity of inhibiting collagen-induced platelet aggregation in flowing whole blood and their use for prophylactic...
|
|
|
7312194 |
Delivery systems
The invention relates to compounds which are useful in the delivery of a wide variety of therapeutically useful molecules. In particular, the invention relates to compounds which are able to act as...
|
|
|
7309697 |
Cyclic maltosylmatose
An object of the present invention is to provide an option of non-reducing saccharide by providing a novel non-reducing saccharide composed of glucose as constituents and to provide a novel enzyme...
|
|
|
7309502 |
Pharmaceutical compositions for treating and saving and the method for the preparation thereof
The present invention relates to a pharmaceutical composition and the method for the preparation thereof. The composition comprises 1.5˜6.9% (w/v) of one or more substances selected from sodium...
|
|
|
7304039 |
Glucose-based compounds with affinity to P-selectin
The present invention relates to certain glucose-based compounds that have an affinity to P-selectin. Further, the invention relates to the use of these glucose-based compounds for the preparation...
|
|
|
7297687 |
Method of treating infectious diseases with polysaccharide derivatives
The present invention relates to a method of treating infectious diseases, that involves: (a) providing an alpha-glycosidically linked starch polysaccharide derivative; and (b) inhibiting the...
|
|
|
7291607 |
Isomaltooligosaccharides from Leuconostoc as neutraceuticals
Isomaltooligosaccharides (IMOs) produced by Leuconostoc mesenteroides ATCC 13146 fermentation with a sucrose:maltose ratio of 2:1 have been discovered to be effective prebiotics in mixed cultures...
|
|
|
7273729 |
Chondroitin synthase and DNA encoding the enzyme
A human-derived novel chondroitin synthase, which is an enzyme for synthesizing a fundamental backbone of chondroitin and has both glucuronic acid transferase activity and N-acetylgalactosamine...
|
|
|
7271158 |
Treatment of rumen acidosis with α-amylase inhibitors
The invention described herein relates to: the use of an effective inhibitor of a bacterial α-amylase and/or α-glucosidase in the manufacture of a composition for the treatment of acidosis; a...
|
|
|
7268122 |
Use of oversulfated polysaccharides as inhibitors of HIV
The present invention relates to the use of N,O oversulfated K5 derivatives having a degree of sulfation higher than 3.2 or of their pharmaceutically acceptable salts for the preparation of...
|
|
|
7262180 |
Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye
The present invention relates to compositions comprising telmesteine, glycyrrhetinic acid, and a proanthocyanidin, as well as methods for using such compositions in the treatment of an inflammatory...
|
|
|
7262179 |
Wound care compositions
Compositions for the treatment of wounds and skin injuries are described. The compositions, which include gellan gum, increases in viscosity once applied to the wound to form an immobile gel. The...
|
|
|
RE39789 |
Tumor therapy
Neoplasia is treated by administering to a mammalian host a composition comprising ligands for the NKG2D receptor. In addition, other NKG2D ligands, proteins specific for the neoplastic cells and...
|
|
|
7259153 |
Drug formulation and delivery using crystalline methylated cyclodextrins
The present invention is directed to pharmaceutical compositions containing crystalline methylated cyclodextrins, which enhance the solubility of the pharmaceutically active agent or agents of the...
|
|
|
7259152 |
Methods and compositions using sulodexide for the treatment of diabetic nephropathy
The present invention provides oral formulations of Sulodexide for the treatment of diabetic nephropathy in patients with both insulin dependent and non-insulin dependent diabetes mellitus. Oral...
|
|
|
7256171 |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
This invention provides compounds and methods for treating inflammation. The compounds modulate the core 2 oligosaccharide-mediated binding of inflammatory cells, such as neutrophils, to...
|
|
|
7253152 |
Electrically conductive polymeric biomaterials, the process for their preparation and the use thereof in the biomedical and healthcare field
The present invention concerns the preparation of composite biomaterials constituted by hyaluronic acid and the derivatives thereof in combination with polymers that have electrically conductive...
|
|
|
7252828 |
Polysaccharide vaccine for staphylococcal infections
The invention relates to compositions of the capsular polysaccharide/adhesin (PS/A) of staphylococci . The PS/A may be isolated or synthesized and includes various modifications to the structure...
|
|
|
7241735 |
Pharmacologically active polypeptide glycoconjugates
The invention relates to glycopeptidic glycoconjugates, in which the polysaccharide is obtained from Candida utilis cells and the peptides are obtained from Ricinus communis seeds. The...
|
|
|
7238677 |
Prevention of urogenital infections
The invention provides hyaluronic acid compounds and derivatives thereof for preventing urogenital infections by a variety of pathogens, as well as compositions, articles and methods for treating...
|
|
|
7235536 |
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
The invention relates to the treating, inhibiting or preventing of certain infectious agents including papilloma virus and various vaginitis-causing microbes by employing cellulose sulfate and...
|